CA2568609A1 - Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees - Google Patents

Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees Download PDF

Info

Publication number
CA2568609A1
CA2568609A1 CA002568609A CA2568609A CA2568609A1 CA 2568609 A1 CA2568609 A1 CA 2568609A1 CA 002568609 A CA002568609 A CA 002568609A CA 2568609 A CA2568609 A CA 2568609A CA 2568609 A1 CA2568609 A1 CA 2568609A1
Authority
CA
Canada
Prior art keywords
substituted
aryl
alkyl
alkenyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002568609A
Other languages
English (en)
Inventor
Rene C. Gaudreault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marusyk Miller & Swain / Mbm & Co LLP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2568609A1 publication Critical patent/CA2568609A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002568609A 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees Abandoned CA2568609A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47411503P 2003-05-28 2003-05-28
US60/474,115 2003-05-28
PCT/CA2004/000772 WO2004106292A1 (fr) 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees

Publications (1)

Publication Number Publication Date
CA2568609A1 true CA2568609A1 (fr) 2004-12-09

Family

ID=33490695

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002568609A Abandoned CA2568609A1 (fr) 2003-05-28 2004-05-28 Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees

Country Status (2)

Country Link
CA (1) CA2568609A1 (fr)
WO (1) WO2004106292A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101691954B1 (ko) * 2016-04-26 2017-01-02 고려대학교 산학협력단 신규 n-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT311956B (de) * 1971-06-07 1973-12-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze
DE2806213A1 (de) * 1978-02-14 1979-08-16 Bayer Ag N-(omega-chloralkanoyl)-n'-trifluormethylphenyl-harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel
JPS61191667A (ja) * 1985-02-21 1986-08-26 Tokuyama Soda Co Ltd 尿素化合物
CA2116621C (fr) * 1993-03-03 2001-07-24 Rene C. Gaudreault Agents anticancereux
US5750547A (en) * 1995-01-06 1998-05-12 Universite Laval Certain carbanate anti-cancer agents

Also Published As

Publication number Publication date
WO2004106292A1 (fr) 2004-12-09

Similar Documents

Publication Publication Date Title
RU2247109C9 (ru) Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf
DE69724811T2 (de) Pentafluorobenzensulfonamide und analoge
EP1311478B1 (fr) Nouveaux composes de (thio)uree et les compositions pharmaceutiques les contenant
EP1506166B1 (fr) Modulateurs de l'uree derives de l'aminotetraline du recepteur vanilloide vr1
US6506778B2 (en) Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
RU2696581C2 (ru) Производные n-мочевинозамещенных аминокислот как модуляторы формил-пептидного рецептора
CN104010501A (zh) 含src同源区2蛋白酪胺酸磷酸酶-1增效剂及其治疗方法
JPH026456A (ja) Ｎ‐〔〔（２，６‐ジ置換）フエニル〕‐ｎ′‐アリールアルキル〕尿素
JP4335131B2 (ja) ヒドロキシテトラヒドロ−ナフタレニル尿素誘導体
US6294695B1 (en) Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
CA1255299A (fr) Derives de guanidinothiazole renfermant des ponts alcoylene; preparation et utilisation comme medicaments
KR100556158B1 (ko) 신규 엔-하이드록시 티오우레아, 우레아 및 아미드계화합물 및 이를 함유하는 약제학적 조성물
JP5042015B2 (ja) 骨状態を治療するための治療薬としてのアリールアルキルスルホンアミド類
EP1129084B1 (fr) Derives de thiazole en tant que ligands de ppar gamma
DE602004010514T2 (de) Ketone und reduzierte ketone als therapeutische mittel zur behandlung von knochenerkrankungen
CA2568609A1 (fr) Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees
US9550746B2 (en) Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators
JP2003192659A (ja) フェニル尿素誘導体
US9365533B2 (en) Coumarin derivative
JPH08301841A (ja) スクアレン・エポキシダーゼ活性阻害剤
US6872748B2 (en) Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
WO2003027064A1 (fr) Analogues simplifies de resiniferatoxine utilises en tant qu'agonistes des recepteurs vanilloide presentant une excellente activite analgesique, et compositions pharmaceutiques contenant ces analogues
EP2573078B1 (fr) Composés d'acrylamide et leur utilisation dans l'inhibition de l'apoptose
DE69806411T2 (de) Neue antiarrythmische verbindungen
CA2518700A1 (fr) Agonistes muscariniques

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead